"Actin"g on GLUT4: Membrane & cytoskeletal components of insulin action

Current Diabetes Reviews

Volumn 3, Issue 2, 2007, Pages 111-122

  Brozinick Jr , Joseph T ^a   Berkemeier, Bradley A ^b   Elmendorf, Jeffrey S ^b  

^a ELI LILLY AND COMPANY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Glucose transport; Insulin resistance; Signaling; Trafficking

Indexed keywords

G ACTIN; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITIDE;

ACTIN FILAMENT; CELL MEMBRANE; CYTOSKELETON; EXOCYTOSIS; GLUCOSE TRANSPORT; HORMONE ACTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN RESISTANCE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CELL MEMBRANE; CYTOSKELETON; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL; PHOSPHATIDYLINOSITOLS; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 34249052338     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339907780598199     Document Type: Review

References (217)

1. Advani A, Marshall SM, Thomas TH. Impaired neutrophil actin assembly causes persistent CD11b expression and reduced primary granule exocytosis in Type II diabetes. Diabetologia 2002; 45(5): 719-27.
2. Advani A, Marshall SM, Thomas TH. Increasing neutrophil F-actin corrects CD11b exposure in Type 2 diabetes. Eur J Clin Invest 2004; 34(5): 358-64.
3. Candiloros H, Zeghari N, Ziegler O, Donner M, Drouin P. Hyperinsulinemia is related to erythrocyte phospholipid composition and membrane fluidity changes in obese nondiabetic women. J Clin Endocrinol Metab 1996; 81(8): 2912-8.
4. Younsi M, Quilliot D, Al-Makdissy N, et al. Erythrocyte membrane phospholipid composition is related to hyperinsulinemia in obese nondiabetic women: effects of weight loss. Metabolism 2002; 51(10):1261-8.
5. Kane S, Sano H, Liu SC, et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem 2002; 277(25):22115-8.
6. Bruss MD, Arias EB, Lienhard GE, Cartee GD. Increased phosphorylation of Akt substrate of 160 kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 2005; 54(1):41-50.
7. Karlsson HK, Zierath JR, Kane S, Krook A, Lienhard GE, Wallberg-Henriksson H. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 2005; 54(6): 1692-7.
8. Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase-activating protein regulates GLUT4 translocation. J Biol Chem. 2003 Apr 25; 278(17): 14599-602.
9. McCarthy AM, Elmendorf JS. Phosphatidylinostol 4,5-bisphosphate and cortical F-actin abnormalities in insulin resistant skeletal muscle. Diabetes. 2005; 54(Suppl 1): A319.
10. Jordens I, Marsman M, Kuijl C, Neefjes J. Rab proteins, connecting transport and vesicle fusion. Traffic 2005; 6(12): 1070-7.
11. Larance M, Ramm G, Stockli J, et al. Characterization of the role of the Rab GTPase-activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 2005; 280(45): 37803-13.
12. Miinea CP, Sano H, Kane S, et al. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase-activating protein domain. Biochem J 2005; 391(Pt 1): 87-93.
13. Elmendorf JS, Pessin JE. Insulin signaling regulating the trafficking and plasma membrane fusion of GLUT4-containing intracellular vesicles. Exp Cell Res 1999; 253(1): 55-62.
14. Eguez L, Lee A, Chavez JA, et al. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab 2005; 2(4): 263-72.
15. Zeigerer A, McBrayer MK, McGraw TE. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. Mol Biol Cell 2004; 15(10): 4406-15.
16. Ribon V, Saltiel AR. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem J 1997; 324: 839-46.
17. Liu J, DeYoung SM, Hwang JB, O'Leary EE, Saltiel AR. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J Biol Chem 2003; 19; 278(38): 36754-62.
18. Ribon V, Printen JA, Hoffman NG, Kay BK, Saltiel AR. A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3-L1 adipocytes. Mol Cell Biol 1998; 18(2): 872-9.
19. Liu J, Kimura A, Baumann CA, Saltiel AR. APS facilitates c-Cbl tyrosine phosphorylation and GLUT4 translocation in response to insulin in 3T3-L1 adipocytes. Mol Cell Biol 2002; 22(11): 3599-609.
20. Chiang SH, Baumann CA, Kanzaki M, et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001; 410(6831): 944-8.
21. Watson RT, Shigematsu S, Chiang SH, et al. Lipid raft microdomain compartmentalization of TC10 is required for insulin signaling and GLUT4 translocation. J Cell Biol 2001; 154(4): 829-40.
22. Baumann CA, Ribon V, Kanzaki M, et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000; 407(6801): 202-7.
23. Chunqiu Hou J, Pessin JE. Lipid Raft Targeting of the TC10 Amino Terminal Domain Is Responsible for Disruption of Adipocyte Cortical Actin. Mol Biol Cell 2003 14(9): 3578-91.
24. Inoue M, Chang L, Hwang J, Chiang SH, Saltiel AR. The exocyst complex is required for targeting of Glut4 to the plasma membrane by insulin. Nature 2003 10; 422(6932): 629-33.
25. Jiang ZY, Chawla A, Bose A, Way M, Czech MP. A phosphatidylinositol 3-kinase-independent insulin signaling pathway to N-WASP/Arp2/3/F-actin required for GLUT4 glucose transporter recycling. J Biol Chem 2002; 277(1): 509-15.
26. Kanzaki M, Pessin JE. Insulin-stimulated GLUT4 translocation in adipocytes is dependent upon cortical actin remodeling. J Biol Chem 2001 9; 276(45): 42436-44.
27. Kanzaki M, Watson RT, Hou JC, Stamnes M, Saltiel AR, Pessin JE. Small GTP-binding protein TC10 differentially regulates two distinct populations of filamentous actin in 3T3L1 adipocytes. Mol Biol Cell 2002; 13(7): 2334-46.
28. Kanzaki M, Pessin JE. Caveolin-associated filamentous actin (Cavactin) defines a novel F-actin structure in adipocytes. J Biol Chem 2002; 277(29): 25867-9.
29. Maffucci T, Brancaccio A, Piccolo E, Stein RC, Falasca M. Insulin induces phosphatidylinositol-3-phosphate formation through TC10 activation. EMBO J 2003; 22(16): 4178-89.
30. Downes CP, Gray A, Lucocq JM. Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol 2005; 15(5): 259-68.
31. Parker PJ. The ubiquitous phosphoinositides. Biochem Soc Trans 2004; 32(Pt 6): 893-8.
32. Roth MG. Phosphoinositides in constitutive membrane traffic. Physiol Rev 2004; 84(3): 699-730.
33. Michell RH, Hawthorne JN, Coleman, R, Karnovsky ML. Extraction of polyphosphoinositides with neutral and acidified solvents. A comparison of guinea-pig brain and liver, and measurements of rat liver inositol compounds which are resistant to extraction. Biochim Biophys Acta 1970; 210(1): 86-91.
34. Vanhaesebroeck B, Leevers SJ, Ahmadi K, et al. Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem 2001; 70: 535-602.
35. Yin HL, Janmey PA. Phosphoinositide regulation of the actin cytoskeleton. Annu Rev Physiol 2003; 65: 761-89.
36. Hartwig JH, Bokoch GM, Carpenter CL, et al. Thrombin receptor ligation and activated Rac uncap actin filament barbed ends through phosphoinositide synthesis in permeabilized human platelets. Cell 1995; 82(4): 643-53.
37. Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, Edidin M. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci USA 2003; 100(24): 13964-9.
38. van Rheenen J, Jalink K. Agonist-induced PIP(2) hydrolysis inhibits cortical actin dynamics: regulation at a global but not at a micrometer scale. Mol Biol Cell 2002; 13(9): 3257-67.
39. Foti M, Audhya A, Emr SD. Sac1 lipid phosphatase and Stt4 phosphatidylinositol 4-kinase regulate a pool of phosphatidylinositol 4-phosphate that functions in the control of the actin cytoskeleton and vacuole morphology. Mol Biol Cell 2001; 12(8):2396-411.
40. DiNubile MJ, Huang S. High concentrations of phosphatidylinositol-4,5-bisphosphate may promote actin filament growth by three potential mechanisms: inhibiting capping by neutrophil lysates, severing actin filaments and removing capping protein-beta2 from barbed ends. Biochim Biophys Acta 1997; 1358(3): 261-78.
41. Payrastre B, Missy K, Giuriato S, Bodin S, Plantavid M, Gratacap M. Phosphoinositides: key players in cell signalling, in time and space. Cell Signal 2001; 13(6): 377-87.
42. Corgan AM, Singleton C, Santoso CB, Greenwood JA. Phosphoinositides differentially regulate alpha-actinin flexibility and function. Biochem J 2004; 378(Pt 3): 1067-72.
43. Fievet BT, Gautreau A, Roy C, et al. Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin. J Cell Biol 2004; 164(5): 653-9.
44. Fraley TS, Pereira CB, Tran TC, Singleton C, Greenwood JA. Phosphoinositide binding regulates alpha-actinin dynamics: mechanism for modulating cytoskeletal remodeling. J Biol Chem 2005; 280(15): 15479-82.
45. Hamada K, Shimizu T, Matsui T, Tsukita S, Hakoshima T. Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain. EMBO J 2000; 19(17): 4449-62.
46. Heiska L, Alfthan K, Gronholm M, Vilja P, Vaheri A, Carpen O. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidyfinositol 4, 5-bisphosphate. J Biol Chem 1998; 273(34): 21893-900.
47. Iijima. M, Devreotes P. Tumor suppressor PTEN mediates sensing of chemoattractant gradients. Cell 2002; 109(5): 599-610.
48. Imai K, Nonoyama S, Miki H, et al. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton. Clin Immunol 1999; 92(2): 128-37.
49. Kam JL, Miura K, Jackson TR, et al. Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site. J Biol Chem 2000; 275(13): 9653-63.
50. Xian W, Janmey PA. Dissecting the gelsolin-polyphosphoinositide interaction and engineering of a polyphosphoinositide-sensitive gelsolin C-terminal half protein. J Mol Biol 2002; 322(4): 755-71.
51. Yamamoto M, Hilgemann DH, Feng S, et al. Phosphatidylinositol 4,5-bisphosphate induces actin stress-fiber formation and inhibits membrane ruffling in CV1 cells. J Cell Biol 2001; 152(5): 867-76.
52. Yang SA, Carpenter CL, Abrams CS. Rho and Rho-kinase mediate thrombin-induced phosphatidylinositol 4-phosphate 5-kinase trafficking in platelets. J Biol Chem 2004; 279(40): 42331-6.
53. Yonemura S, Matsui T, Tsukita S. Rho-dependent and - independent activation mechanisms of ezrin/radixin/moesin proteins: an essential role for polyphosphoinositides in vivo. J Cell Sci 2002; 115(Pt 12): 2569-80.
54. Dormann D, Weijer G, Dowler S, Weijer CJ. In vivo analysis of 3-phosphoinositide dynamics during Dictyostelium phagocytosis and chemotaxis. J Cell Sci 2004; 117(Pt 26): 6497-509.
55. Shisheva A. Regulating Glut4 vesicle dynamics by phosphoinositide kinases and phosphoinositide phosphatases. Front Biosci 2003; 8: s945-6.
56. Huang S, Lifshitz L, Patki-Kamath V, Tuft R, Fogarty K, Czech MP. Phosphatidylinositol-4,5-bisphosphate-rich plasma membrane patches organize active zones of endocytosis and ruffling in cultured adipocytes. Mol Cell Biol 2004; 24(20): 9102-23.
57. Standaert ML, Galloway L, Kamam P, Bandyopadhyay G, Moscat J, Farese RV. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J Biol Chem 1997; 272(48): 30075-82.
58. Standaert ML, Bandyopadhyay G, et al. Insulin activates protein kinases C-zeta and C-lambda by an autophosphorylation-dependent mechanism and stimulates their translocation to GLUT4 vesicles and other membrane fractions in rat adipocytes. J Biol Chem 1999; 274(36): 25308-16.
59. Bandyopadhyay G, Standaert ML, Galloway L, Moscat J, Farese RV. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology 1997; 138(11): 4721-31.
60. Kotani K, Ogawa W, Matsumoto M, et al. Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol Cell Biol 1998; 18(12): 6971-82.
61. Mendez R, Kollmorgen G, White MF, Rhoads RE. Requirement of protein kinase C zeta for stimulation of protein synthesis by insulin. Mol Cell Biol 1997; 17(9): 5184-92.
62. Yang C, Watson RT, Elmendorf JS, Sacks DB, Pessin JE. Calmodulin antagonists inhibit insulin-stimulated GLUT4 (glucose transporter 4) translocation by preventing the formation of phosphatidylinositol 3,4,5-trisphosphate in 3T3L1 adipocytes. Mol Endocrinol 2000; 14(2): 317-26.
63. Tengholm A, Teruel MN, Meyer T. Single cell imaging of PI3K activity and glucose transporter insertion into the plasma membrane by dual color evanescent wave microscopy. Sci STKE 2003; 2003(169): L4.
64. Vollenweider P, Clodi M, Martin SS, Imamura T, Kavanaugh WM, Olefsky JM. An SH2 domain-containing 5′ inositolphosphatase inhibits insulin-induced GLUT4 translocation and growth factor-induced actin filament rearrangement. Mol Cell Biol 1999; 19(2): 1081-91.
65. Wada T, Sasaoka T, Funaki M, et al. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5′-phosphatase catalytic activity. Mol Cell Biol 2001; 21(5): 1633-46.
66. Ijuin T, Takenawa. T. SKIP negatively regulates insulin-induced GLUT4 translocation and membrane ruffle formation. Mol Cell Biol 2003; 23(4): 1209-20.
67. Nakashima N, Sharma PM, Imamura. T, Bookstein F, Olefsky JM. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 2000; 275(17): 12889-95.
68. Egawa K, Nakashima N, Sharma PM, et al. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Endocrinology 2000; 141(6): 1930-5.
69. Tengholm A, Meyer T. A PI3-kinase signaling code for insulin-triggered insertion of glucose transporters into the plasma membrane. Curr Biol 2002; 12(21): 1871-6.
70. Oatey PB, Venkateswarlu K, Williams AG, et al. Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes. Biochem J 1999; 344(Pt 2): 511-8.
71. Sweeney G, Garg RR, Ceddia RB, et al. Intracellular delivery of phosphatidylinositol (3,4,5)-trisphosphate causes incorporation of glucose transporter 4 into the plasma membrane of muscle and fat cells without increasing glucose uptake. J Biol Chem 2004; 279(31): 32233-42.
72. Eichhorn J, Kayali AG, Austin DA, Webster NJ. Insulin activates phospholipase C-gammal via a PI-3 kinase dependent mechanism in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2001; 282(2): 615-20.
73. Kayali AG, Eichhorn J, Haruta T, et al. Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin. J Biol Chem 1998; 273(22): 13808-18.
74. Van Epps-Fung M, Gupta K, Hardy RW, Wells A. A role for phospholipase C activiry in GLUT4-mediated glucose transport. Endocrinology 1997; 138(12): 5170-5.
75. Sbrissa D, Ikonomov OC, Strakova J, Shisheva A. Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation. Endocrinology 2004; 145(11): 4853-65. Epub 2004 Jul 29.
76. Wenk MR, De Camilli P. Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals. Proc Natl Acad Sci USA 2004; 101 (22): 8262-9.
77. Ishiki M, Randhawa VK, Poon V, Jebailey L, Klip A. Insulin regulates the membrane arrival, fusion and C-terminal unmasking of Glut4 via distinct phosphoinositides. J Biol Chem 2005; 13: 13.
78. Hay JC, Fisette PL, Jenkins GH, et al. ATP-dependent inositide phosphorylation required for Ca(2+)-activated secretion. Nature 1995; 374(6518): 173-7.
79. Hay JC, Martin TF. Phosphatidylinositol transfer protein required for ATP-dependent priming of Ca(2+)-activated secretion. Nature 1993; 366(6455): 572-5.
80. Eberhard DA, Cooper CL, Low MG, Holz RW. Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. Biochem J 1990; 268(1): 15-25.
81. Bittner MA, Holz RW. Phosphatidylinositol-4,5-bisphosphate: actin dynamics and the regulation of ATP-dependent and -independent secretion. Mol Pharmacol 2005; 67(4): 1089-98.
82. Cormont M, Tanti JF, Zahraoui A, Van Obberghen E, Tavitian A, Le Marchand-Brustel Y. Insulin and okadaic acid induce Rab4 redistribution in adipocytes. J Biol Chem 1993; 268(26): 19491-7.
83. Cormont M, Van Obberghen E, Zerial M, Le Marchand-Brustel Y. Insulin induces a change in Rab5 subcellular localization in adipocytes independently of phosphatidylinositol 3-kinase activation. Endocrinology 1996; 137(8): 3408-15.
84. Shibata H, Omata W, Suzuki Y, Tanaka S, Kojima I. A synthetic peptide corresponding to the Rab4 hypervariable carboxyl-terminal domain inhibits insulin action on glucose transport in rat adipocytes J Biol Chem 1996; 271(16): 9704-9.
85. Mora S, Monden I, Zorzano A, Keller K. Heterologous expression of rab4 reduces glucose transport and GLUT4 abundance at the cell surface in oocytes. Biochem J 1997; 324(Pt 2): 455-9.
86. Li L, Omata W, Kojima I, Shibata H. Direct interaction of Rab4 with syntaxin 4. J Biol Chem 2001; 276(7): 5265-73.
87. Kanda H, Tamori Y, Shinoda H, et al. Adipocytes from Munc18c-null mice show increased sensitivity to insulin-stimulated GLUT4 externalization. J Clin Invest 2005; 115(2): 291-301.
88. Kan AW, Ceresa BP, Santeler SR, Pessin JE. Expression of a dominant interfering dynamin mutant in 3T3L1 adipocytes inhibits GLUT4 endocytosis without affecting insulin signaling. J Biol Chem 1998; 273(39): 25450-7.
89. Ceresa BP, Kao AW, Santeler SR, Pessin JE. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Mol Cell Biol 1998; 18(7): 3862-70.
90. Volchuk A, Narine S, Foster LJ, Grabs D, De Camilli P, Klip A. Perturbation of dynamin II with an amphiphysin SH3 domain increases GLUT4 glucose transporters at the plasma membrane in 3T3-L1 adipocytes. Dynamin II participates in GLUT4 endocytosis. J Biol Chem 1998; 273(14): 8169-76.
91. Al-Hasani H, Hinck CS, Cushman SW. Endocytosis of the glucose transporter GLUT4 is mediated by the GTPase dynamin. J Biol Chem 1998; 273(28): 17504-10.
92. Hoy M, Efanov AM, Bertorello AM, et al. Inositol hexakisphosphate promotes dynamin I- mediated endocytosis. Proc Natl Acad Sci USA 2002; 99(10): 6773-7.
93. Barylko B, Binns DD, Albanesi JP. Activation of dynamin GTPase activity by phosphoinositides and SH3 domain-containing proteins. Methods Enzymol 2001; 329:486-96.
94. Lin HC, Barylko B, Achiriloaie M, Albanesi JP. Phosphatidylinositol (4,5)-bisphosphate-dependent activation of dynamins I and II lacking the proline/arginine-rich domains. J Biol. Chem 1997; 272(41): 25999-6004.
95. Salim K, Bottomley MJ, Querfurth E, et al. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J 1996; 15(22):6241-50.
96. Lin HC, Gilman AG. Regulation of dynamin I GTPase activity by G protein betagamma subunits and phosphatidylinositol 4,5-bisphosphate. J Biol Chem 1996; 271(45): 27979-82.
97. von Stein W, Ramrath A, Grimm A, Muller-Borg M, Wodarz A. Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 2005; 132(7): 1675-86.
98. Wang Q, Xie Y, Du QS, et al. Regulation of the formation of osteoclastic actin rings by proline-rich tyrosine kinase 2 interacting with gelsolin. J Cell Biol 2003; 160(4): 565-75.
99. Chavez JA, Knotts TA, Wang LP, et al. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 2003; 278(12): 10297-303.
100. Bertagnolo V, Brugnoli F, Marchisio M, Capitani S. Inositide-modifying enzymes: a cooperative role in regulating nuclear morphology during differentiation of myeloid cells. J Biol Regul Homeost Agents 2004; 18(3-4): 381-6.
101. Bodin S, Soulet C, Tronchere H, et al. Integrin-dependent interaction of lipid rafts with the actin cytoskeleton in activated human platelets. J Cell Sci 2005; 118(Pt 4): 759-69.
102. Hartwig JH, Barkalow K, Azim A, Italiano J. The elegant platelet: signals controlling actin assembly. Thromb Haemost 1999; 82(2): 392-8.
103. Cabello-Agueros JF, Hernandez-Gonzalez EO, Mujica A. The role of F-actin cytoskeleton-associated gelsolin in the guinea pig capacitation and acrosome reaction. Cell Motil Cytoskeleton 2003; 56(2): 94-108.
104. Omata W, Shibata H, Li L, Takata K, Kojima I. Actin filaments play a critical role in insulin-induced exocytotic recruitment but not in endocytosis of GLUT4 in isolated rat adipocytes. Biochem J 2000; 346(Pt 2): 321-8.
105. Tsakiridis T, Bergman A, Somwar R, et al. Actin filaments facilitate insulin activation of the src and collagen homologous/ mitogen-activated protein kinase pathway leading to DNA synthesis and c-fos expression. J Biol Chem 1998; 273(43): 28322-31.
106. Bose A, Guilherme A, Robida SI, et al. Glucose transporter recycling in response to insulin is facilitated by myosin Myo 1c. Nature 2002; 420(6917): 821-4.
107. Chen G, Raman P, Bhonagiri P, Strawbridge AB, Pattar GR, Elmendorf JS. Protective effect of phosphatidylinositol 4,5-bisphosphate against cortical filamentous actin loss and insulin resistance induced by sustained exposure of 3T3-L1 adipocytes to insulin. J Biol Chem 2004; 279(38): 39705-9.
108. Eyster CA, Duggins QS, Olson AL. Expression of constitutively active Akt/ protein kinase B signals GLUT4 translocation in the absence of an intact actin cytoskeleton. J Biol Chem 2005; 280(18): 17978-85.
109. Kanzaki M, Watson RT, Khan AH, Pessin JE. Insulin stimulates actin comet tails on intracellular GLUT4-containing compartments in differentiated 3T3L1 adipocytes. J Biol Chem 2001; 276(52): 49331-6.
110. Lu PJ, Shieh WR, Rhee SG, Yin HL, Chen CS. Lipid products of phosphoinositide 3-kinase bind human profilin with high affinity. Biochemistry 1996; 35(44): 14027-34.
111. Bose A, Cherniack AD, Langille SE, et al. G(alpha)11 signaling through ARF6 regulates F-actin mobilization and GLUT4 glucose transporter translocation to the plasma membrane. Mol Cell Biol 2001; 21(15): 5262-75.
112. Biswas RS, Baker D, Hruska KA, Chellaiah MA. Polyphosphoinositides-dependent regulation of the osteoclast actin cytoskeleton and bone resorption. BMC Cell Biol 2004; 5(1): 19.
113. Caroni P. New EMBO members' review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J 2001; 20(16): 4332-6.
114. Fernandis AZ, Srivastava R, Sinha RK, Subrahmanyam G. A type II phosphatidylinositol 4-kinase associates with T cell receptor zeta chain in Con A stimulated splenic lymphocytes through tyrosyl phosphorylation-dependent mechanisms. Mol Immunol 2005; 42(5):561-8.
115. Purushothaman SS, Wang B, Cleary PP. M1 protein triggers a phosphoinositide cascade for group A Streptococcus invasion of epithelial cells. Infect Immun 2003; 71(10): 5823-30.
116. Patel N, Rudich A, Khayat ZA, Garg R, Klip A. Intracellular segregation of phosphatidylinositol-3,4,5-trisphosphate by insulin-dependent actin remodeling in L6 skeletal muscle cells. Mol Cell Biol 2003; 23(13): 4611-26.
117. Tsakiridis T, Vranic M, Klip A. Disassembly of the actin network inhibits insulin-dependent stimulation of glucose transport and prevents recruitment of glucose transporters to the plasma membrane. J Biol Chem 1994; 269(47): 29934-42.
118. Peyrollier K, Hajduch E, Gray A, et al. A role for the actin cytoskeleton in the hormonal and growth-factor-mediated activation of protein kinase B. Biochem J 2000; 352 (Pt 3): 617-22.
119. Brozinick JT, Jr., Hawkins ED, Strawbridge AB, Elmendorf JS. Disruption of cortical actin in skeletal muscle demonstrates an essential role of the cytoskeleton in glucose transporter 4 translocation in insulin-sensitive tissues. J Biol Chem 2004; 279(39): 40699-706.
120. Martin SS, Haruta T, Morris AJ, Klippel A, Williams LT, Olefsky JM. Activated phosphatidylinositol 3-kinase is sufficient to mediate actin rearrangement and GLUT4 translocation in 3T3-L1 adipocytes. J Biol Chem 1996; 271: 17605-8.
121. Gual P, Shigematsu S, Kanzaki M, et al. A Crk-II/TC10 signaling pathway is required for osmotic shock-stimulated glucose transport. J Biol Chem 2002; 4: 4.
122. JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A, Klip A. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol Endocrinol 2004; 18(2): 359-72.
123. Khayat ZA, Tong P, Yaworsky K, Bloch RJ, Klip A. Insulin-induced actin filament remodeling colocalizes actin with phosphatidylinositol 3-kinase and GLUT4 in L6 myotubes. J Cell Sci 2000; 11 3(Pt 2): 279-90.
124. Terada S, Hirokawa N. Moving on to the cargo problem of microtubule-dependent motors in neurons. Curr Opin Neurobiol 2000; 10(5): 566-73.
125. Apodaca G. Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton. Traffic 2001; 2(3): 149-59.
126. Stamnes M. Regulating the actin cytoskeleton during vesicular transport. Curr Opin Cell Biol 2002; 14(4): 428-33.
127. Schafer DA. Coupling actin dynamics and membrane dynamics during endocytosis. Curr Opin Cell Biol 2002; 14(1): 76-81.
128. Patki V, Buxton J, Chawla A, et al. Insulin action on GLUT4 traffic visualized in single 3T3-11 adipocytes by using ultra-fast microscopy. Mol Biol Cell 2001; 12(1): 129-41.
129. Semiz S, Park JG, Nicoloro SM, et al. Conventional kinesin KIF5B mediates insulin-stimulated GLUT4 movements on microtubules. EMBO J 2003; 22(10): 2387-99.
130. Olson AL, Eyster CA, Duggins QS, Knight JB. Insulin promotes formation of polymerized microtubules by a phosphatidylinositol 3-kinase-independent, actin-dependent pathway in 3T3-L1 adipocytes. Endocrinology 2003; 144(11): 5030-9.
131. Wang Q, Bilan PJ, Tsakiridis T, Hinek A, Klip A. Actin filaments participate in the relocalization of phosphatidylinositol3-kinase to glucose transporter-containing compartments and in the stimulation of glucose uptake in 3T3-L1 adipocytes [published erratum appears in Biochem J 1999 1; 341 (Pt 3): 861]. Biochem J 1998; 331 (Pt 3): 917-28.
132. Kanzaki M, Furukawa M, Raab W, Pessin JE. Phosphatidylinositol 4,5-bisphosphate regulates adipocyte actin dynamics and GLUT4 vesicle recycling. J Biol Chem 2004; 279(29): 30622-33.
133. Kandror KV, Pilch PF. gp 160, a tissue-specific marker for insulin-activated glucose transport. Proc Natl Acad Sci USA 1994; 91(17): 8017-21.
134. Kandror KV, Yu L, Pilch PF. The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity. J Biol Chem 1994; 269(49): 30777-80.
135. Mastick CC, Aebersold R, Lienhard GE. Characterization of a major protein in GLUT4 vesicles. Concentration in the vesicles and insulin-stimulated translocation to the plasma membrane. J Biol Chem 1994; 269(8): 6089-92.
136. Keller SR, Scott HM, Mastick CC, Aebersold R, Lienhard GE. Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles. J Biol Chem 1995; 270(40): 23612-8.
137. Malide D, St-Denis JF, Keller SR, Cushman SW. Vp165 and GLUT4 share similar vesicle pools along their trafficking pathways in rat adipose cells. FEBS Lett 1997; 409(3): 461-8.
138. Ross SA, Herbst JJ, Keller SR, Lienhard GE. Trafficking kinetics of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1997; 239(1): 247-51.
139. Waters SB, D'Auria M, Martin SS, Nguyen C, Kozma LM, Luskey KL. The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes. J Biol Chem 1997; 272(37): 23323-7.
140. Tojo H, Kaieda I, Hattori H, et al. The Formin family protein, formin homolog overexpressed in spleen, interacts with the insulin-responsive aminopeptidase and profilin IIa. Mol Endocrinol 2003; 17(7): 1216-29.
141. Paul DS, Harmon AW, Winston CP, Patel YM. Calpain facilitates GLUT4 vesicle translocation during insulin-stimulated glucose uptake in adipocytes. Biochem J 2003; 376(Pt 3): 625-32.
142. Turner MD, Cassell PG, Hitman GA. Calpain-10: from genome search to function. Diabetes Metab Res Rev 2005; 18: 18.
143. Bedi D, Clarke KJ, Dennis JC, et al. Endothelin-1 inhibits adiponectin secretion through a phosphatidylinositol 4,5-bisphosphate/ actin-dependent mechanism. Biochem Biophys Res Commun 2006; 345(1):332-9.
144. Valentijn JA, Valentijn K, Pastore LM, Jamieson JD. Actin coating of secretory granules during regulated exocytosis correlates with the release of rab3D. Proc Natl Acad Sci USA 2000; 97(3): 1091-5.
145. Muallem S, Kwiatkowska K, Xu X, Yin HL. Actin filament disassembly is a sufficient final trigger for exocytosis in nonexcitable cells. J Cell Biol 1995; 128(4): 589-98.
146. Sontag JM, Aunis D, Bader W. Peripheral actin filaments control calcium-mediated catecholamine release from streptolysin-O-permeabilized chromaffin cells. Eur J Cell Biol 1988; 46(2): 316-26.
147. Lelkes PI, Friedman JE, Rosenheck K, Oplatka A. Destabilization of actin filaments as a requirement for the secretion of catecholamines from permeabilized chromaffin cells. FEBS Lett 1986; 208(2): 357-63.
148. Matter K, Dreyer F, Aktories K. Actin involvement in exocytosis from PC12 cells: studies on the influence of botulinum C2 toxin on stimulated noradrenaline release. J Neurochem 1989; 52(2): 370-6.
149. Li G, Rungger-Brandle E, Just I, Jonas JC, Aktories K, Wollheim CB. Effect of disruption of actin filaments by Clostridium botulinum C2 toxin on insulin secretion in HIT-T15 cells and pancreatic islets. Mol Biol Cell 1994; 5(11):1199-213.
150. Morita K, Oka M, Hamano S. Effects of cytoskeleton-disrupting drugs on ouabain-stimulated catecholamine secretion from cultured adrenal chromaffin cells. Biochem Pharmacol 1988; 37(17): 3357-9.
151. O'Konski MS, Pandol SJ. Cholecystokinin JMV-180 and caerulein effects on the pancreatic acinar cell cytoskeleton. Pancreas 1993; 8(5): 638-46.
152. Randhawa VK, Bilan PJ, Khayat ZA, et al. VAMP2, but Not VAMP3/ Cellubrevin, Mediates Insulin-dependent Incorporation of GLUT4 into the Plasma Membrane of L6 Myoblasts. Mol Biol Cell 2000; 11(7): 2403-17.
153. Tong P, Khayat ZA, Huang C, Patel N, Ueyama A, Klip A. Insulin-induced cortical actin remodeling promotes GLUT4 insertion at muscle cell membrane ruffles. J Clin Invest 2001; 108(3): 371-81.
154. Torok D, Patel N, Jebailey L, et al. Insulin but not PDGF relies on actin remodeling and on VAMP2 for GLUT4 translocation in myoblasts. J Cell Sci 2004; 117(Pt 22): 5447-55.
155. Braiman L, Alt A, Kuroki T, et al. Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle. Mol Cell Biol 2001; 21(22): 7852-61.
156. Elmendorf JS. Fluidity of insulin action. Mol Biotechnol 2004; 27(2): 127-38.
157. Sechi AS, Wehland J. The actin cytoskeleton and plasma membrane connection: PtdIns(4,5)P(2) influences cytoskeletal protein activity at the plasma membrane. J Cell Sci 2000; 113(Pt 21): 3685-95.
158. Chen F, Ma L, Parrini MC, et al. Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol 2000; 10(13): 758-65.
159. Missy K, Van Poucke V, Raynal P, et al. Lipid products of phosphoinositide 3-kinase interact with Racl GTPase and stimulate GDP dissociation. J Biol Chem 1998; 273(46): 30279-86.
160. Clodi M, Vollenweider P, Klarlund J, et al. Effects of general receptor for phosphoinositides 1 on insulin and insulin-like growth factor I-induced cytoskeletal rearrangement, glucose transporter-4 translocation, and deoxyribonucleic acid synthesis. Endocrinology 1998; 139(12,):4984-90.
161. Settleman J. Getting in shape with Rho. Nat Cell Biol 2000; 2(1): E7-9.
162. Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care 1994; 17(12):1449-52.
163. Rabinovitz H, Friedensohn A, Leibovitz A, Gabay G, Rocas C, Habot B. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients. Int J Vitam Nutr Res 2004; 74(3): 178-82.
164. Vladeva SV, Terzieva DD, Arabadjiiska DT. Effect of chromium on the insulin resistance in patients with type II diabetes mellitus. Folia Med (Plovdiv) 2005; 47(3-4): 59-62.
165. Pattar GR, Tackett L, Liu P, Elmendorf JS. Chromium picolinate positively influences the glucose transporter system via affecting cholesterol homeostasis in adipocytes cultured under hyperglycemic diabetic conditions. Mutat Res 2006; 610(1-2): 93-100.
166. Guclu F, Ozmen B, Hekimsoy Z, Kirmaz C. Effects of a statin group drug, pravastatin, on the insulin resistance in patients with metabolic syndrome. Biomed Pharmacother 2004; 58(10): 614-8.
167. Sonmez A, Baykal Y, Kilic M, et al. Fluvastatin improves insulin resistance in nondiabetic dyslipidemic patients. Endocrine 2003; 22(2): 151-4.
168. Suzuki M, Kakuta H, Takahashi A, et al. Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice. J Atheroscler Thromb 2005; 12(2): 77-84.
169. Chen KL, Lu JJ, Lien TF, Chiou PW. Effects of chromium nicotinate on performance, carcase characteristics and blood chemistry of growing turkeys. Br Poult Sci 2001; 42(3): 399-404.
170. Musi N, Hirshman MF, Nygren J, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes 2002; 51(7):2074-81.
171. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001; 108(8): 1167-74.
172. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89(3): 331-40.
173. Thyfault JP, Cree MG, Zheng D, et al. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am J Physiol Cell Physiol 2007; 292(2): C729-39.
174. Huang C, Thirone AC, Huang X, Klip A. Differential contribution of insulin receptor substrates 1 versus 2 to insulin signaling and glucose uptake in 16 myotubes. J Biol Chem 2005; 280(19): 19426-35.
175. Golub T, Pico C. Spatial control of actin-based motility through plasmalemmal PtdIns(4,5)P2-rich raft assemblies. Biochem Soc Symp 2005(72): 119-27.
176. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414(6865): 782-7.
177. Zierath JR, Krook A, Wallberg-Henriksson H. Insulin action and insulin resistance in human skeletal muscle. Diabetologia 2000; 43(7): 821-35.
178. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000; 11(9): 351-6.
179. Deshmukh A, Coffey VG, Zhong Z, Chibalin AV, Hawley JA, Zierath JR. Exercise-induced phosphorylation of the novel akt substrates AS160 and filamin a in human skeletal muscle. Diabetes 2006; 55(6): 1776-82.
180. Garvey WT, Olefsky JM, Marshall S. Insulin receptor down-regulation is linked to an insulin-induced postreceptor defect in the glucose transport system in rat adipocytes. J Clin Invest 1985; 76(1): 22-30.
181. Kozka IJ, Clark AE, Holman GD. Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem 1991; 266(18): 11726-31.
182. Kozka IJ, Holman GD. Metformin blocks downregulation of cell surface GLUT4 caused by chronic insulin treatment of rat adipocytes. Diabetes 1993; 42(8): 1159-65.
183. Garvey WT, Olefsky JM, Matthaei S, Marshall S. Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance. J Biol Chem 1987; 262(1): 189-97.
184. Garvey WT, Olefsky JM, Marshall S. Insulin induces progressive insulin resistance in cultured rat adipocytes. Sequential effects at receptor and multiple postreceptor sites. Diabetes 1986; 35(3): 258-67.
185. Pryor PR, Liu SC, Clark AE, Yang J, Holman GD, Tosh D. Chronic insulin effects on insulin signalling and GLUT4 endocytosis are reversed by metformin. Biochem J 2000; 348(Pt 1): 83-91.
186. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996; 271(5249): 665-8.
187. Brindley DN, Abousalham A, Kikuchi Y, Wang CN, Waggoner DW. "Cross talk" between the bioactive glycerolipids and sphingolipids in signal transduction. Biochem Cell Biol 1996; 74(4): 469-76.
188. Guo D, Donner DB. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. J Biol Chem 1996; 271(2): 615-8.
189. Summers SA, Garza LA, Zhou H, Birnbaum MJ. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol Cell Biol 1998; 18(9): 5457-64.
190. Stratford S, Dewald DB, Summers SA. Ceramide dissociates 3′-phosphoinositide production from pleckstrin homology domain translocation. Biochem J 2001; 354: 359-68.
191. Teruel T, Hernandez R, Lorenzo M. Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 2001; 50(11): 2563-71.
192. Kralik SF, Liu P, Leffler BJ, Elmendorf JS. Ceramide and glucosamine antagonism of alternate signaling pathways regulating insulin- and osmotic shock-induced glucose transporter 4 translocation. Endocrinology 2002; 143(1): 37-46.
193. Marshall S, Bacote V, Traxinger RR. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266(8): 4706-12.
194. Rossetti L. Perspective: Hexosamines and nutrient sensing. Endocrinology 2000; 141(6): 1922-5.
195. McClain DA, Crook ED. Hexosamines and insulin resistance. Diabetes 1996; 45(8): 1003-9.
196. Ross SA, Chen X, Hope HR, et al. Development and comparison of Two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment. Biochem Biophys Res Commun 2000; 273(3): 1033-41.
197. Hawkins M, Hu M, Yu J, et al. Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinisitol 3-kinase activity. J Biol Chem 1999; 274(44): 31312-9.
198. Buse MG, Robinson KA, Marshall BA, Hresko RC, Mueckler MM. Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles. Am J Physiol Endocrinol Metab 2002; 283(2): E241-50.
199. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37(12): 1595-607.
200. Del Prato S, Leonetti F, Simonson DC, Sheehan P, Matsuda M, DeFronzo RA. Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia 1994; 37(10): 1025-35.
201. Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. Production of insulin resistance by hyperinsulinaemia in man. Diabetologia 1985; 28(2): 70-5.
202. Henry RR, Ciaraldi TP, Mudaliar S, Abrams L, Nikoulina SE. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes 1996; 45(4): 400-7.
203. Flores-Riveros JR, McLenithan JC, Ezaki O, Lane MD. Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover, Proc Natl Acad Sci USA 1993; 90(2): 512-6.
204. Ricort JM, Tanti JF, Van Obberghen E, Le Marchand-Brustel Y. Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 1995; 38(10): 1148-56.
205. Nelson BA, Robinson KA, Buse MG. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 2000; 49(6): 981-91.
206. Strawbridge AB, Elmendorf JS. Phosphatidylinositol 4,5-Bisphosphate Reverses Endothelin-1-Induced Insulin Resistance via an Actin-Dependent Mechanism. Diabetes 2005; 54(6): 1698-705.
207. Strawbridge AB, Elmendorf JS. Endothelin-1 impairs glucose transporter trafficking via a membrane-based mechanism. J Cell Biochem 2006; 97(4): 849-56.
208. Jiang ZY, Zhou QL, Chatterjee A, et al. Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes 1999; 48(5): 1120-30.
209. Ishibashi KI, Imamura T, Sharma PM, Huang J, Ugi S, Olefsky JM. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J Clin Invest 2001; 107(9): 1193-202.
210. Wilkes JJ, Hevener A, Olefsky J. Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 2003; 52(8): 1904-9.
211. Ottosson-Seeberger A, Lundberg JM, Alvestrand A, Ahlborg G. Exogenous endothelin-1 causes peripheral insulin resistance in healthy humans. Acta Physiol Scand 1997; 161(2): 211-20.
212. Teuscher AU, Lerch M, Shaw S, Pacini G, Ferrari P, Weidmann P. Endothelin-1 infusion inhibits plasma insulin responsiveness in normal men. J Hypertens 1998; 16(9): 1279-84.
213. Idris I, Patiag D, Gray S, Donnelly R. Tissue- and time-dependent effects of endothelin-1 on insulin-stimulated glucose uptake. Biochem Pharmacol 2001; 62(12): 1705-8.
214. Juan CC, Fang VS, Huang YJ, Kwok CF, Hsu YP, Ho LT. Endothelin-1 induces insulin resistance in conscious rats. Biochem Biophys Res Commun 1996; 227(3): 694-9.
215. Williams MW, Bloch RJ. Extensive but Coordinated Reorganization of the Membrane Skeleton in Myofibers of Dystrophic (mdx) Mice. J Cell Biol 1999; 144(6): 1259-70.
216. Mulvey C, Harno E, Keenan A, Ohlendieck K. Expression of the skeletal muscle dystrophin-dystroglycan complex and syntrophinnitric oxide synthase complex is severely affected in the type 2 diabetic Goto-Kakizaki rat. Eur J Cell Biol 2005; 84(11): 867.
217. Andersen H, Nielsen S, Mogensen CE, Jakobsen J. Muscle Strength in Type 2 Diabetes. Diabetes 2004; 53(6): 1543-8.